Page 45 - JCTR-11-2

Journal of Clinical and
Translational Research miRNA in pneumonia and pulmonary fibrosis

36. Adhanom G, Gebreegziabiher D, Weldu Y, 47. Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ,
Wasihun AG, Araya T, Legese H, et al. Species, Risk Factors, Lynch JP 3 . Idiopathic Pulmonary Fibrosis: Pathogenesis
rd
and Antimicrobial Susceptibility Profiles of Bacterial Isolates and Therapeutic Approaches. Drugs 2004;64:405-30.
from HIV-Infected Patients Suspected to Have Pneumonia
in Mekelle Zone, Tigray, Northern Ethiopia. Biomed Res Int doi: 10.2165/00003495-200464040-00005
2019;2019:8768439. 48. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG,
Brumwell EN, et al. Alveolar Epithelial Cell Mesenchymal
doi: 10.1155/2019/8768439
Transition Develops in vivo During Pulmonary Fibrosis and
37. Huang S, Feng C, Zhai YZ, Zhou X, Li B, Wang LL, et al. is Regulated by the Extracellular Matrix. Proc Natl Acad Sci
Identification of MiRNA Biomarkers of Pneumonia using U S A 2006;103:13180-5.
RNA-Sequencing and Bioinformatics Analysis. Exp Ther
Med 2017;13:1235-44. doi: 10.1073/pnas.0605669103
49. Cadena-Suárez AR, Hernández-Hernández HA, Alvarado-
doi: 10.3892/etm.2017.4151
Vásquez N, Rangel-Escareño C, Sommer B, Negrete-
38. Wuyts WA, Agostini C, Antoniou KM, Bouros D, García MC. Role of MicroRNAs in Signaling Pathways
Chambers RC, Cottin V, et al. The Pathogenesis of Pulmonary Associated with the Pathogenesis of Idiopathic Pulmonary
Fibrosis: A Moving Target. Eur Respir J 2013;41:1207-18. Fibrosis: A Focus on Epithelial-Mesenchymal Transition. Int
doi: 10.1183/09031936.00073012 J Mol Sci 2022;23:6613.
39. Marshall RP, McAnulty RJ, Laurent GJ. The Pathogenesis of doi: 10.3390/ijms23126613
Pulmonary Fibrosis: Is there a Fibrosis Gene? Int J Biochem 50. Condrat CE, Thompson DC, Barbu MG, Bugnar OL,
Cell Biol 1997;29:107-20. Boboc A, Cretoiu D, et al. MiRNAs as Biomarkers in
doi: 10.1016/s1357-2725(96)00141-0 Disease: Latest Findings Regarding Their Role in Diagnosis
and Prognosis. Cells 2020;9:276.
40. She YX, Yu QY, Tang XX. Role of Interleukins in the
Pathogenesis of Pulmonary Fibrosis. Cell Death Discov doi: 10.3390/cells9020276
2021;7:52. 51. Rajasekaran S, Rajaguru P, Sudhakar Gandhi PS. MicroRNAs
doi: 10.1038/s41420-021-00437-9 as Potential Targets for Progressive Pulmonary Fibrosis.
Front Pharmacol 2015;6:254.
41. Sgalla G, Iovene B, Calvello M, Ori M, Varone F,
Richeldi L. Idiopathic Pulmonary Fibrosis: Pathogenesis doi: 10.3389/fphar.2015.00254
and Management. Respir Res 2018;19:32. 52. Liu B, Jiang T, Hu X, Liu Z, Zhao L, Liu H, et al.
doi: 10.1186/s12931-018-0730-2 Downregulation of MicroRNA-30a in Bronchoalveolar
Lavage Fluid from Idiopathic Pulmonary Fibrosis Patients.
42. Bellaye PS, Kolb M. Why Do Patients Get Idiopathic Mol Med Rep 2018;18:5799-806.
Pulmonary Fibrosis? Current Concepts in the Pathogenesis
of Pulmonary Fibrosis. BMC Med 2015;13:176. doi: 10.3892/mmr.2018.9565
doi: 10.1186/s12916-015-0412-6 53. Wang M, Huang Y, Liang Z, Liu D, Lu Y, Dai Y, et al. Plasma
MiRNAs Might Be Promising Biomarkers of Chronic
43. Oikonomou N, Mouratis MA, Tzouvelekis A, Obstructive Pulmonary Disease. Clin Respir J 2016;10:104-11.
Kaffe E, Valavanis C, Vilaras G, et al. Pulmonary Autotaxin
Expression Contributes to the Pathogenesis of Pulmonary doi: 10.1111/crj.12194
Fibrosis. Am J Respir Cell Mol Biol 2012;47:566-74. 54. Njock MS, Guiot J, Henket MA, Nivelles O, Thiry M,
doi: 10.1165/rcmb.2012-0004OC Dequiedt F, et al. Sputum Exosomes: Promising Biomarkers
for Idiopathic Pulmonary Fibrosis. Thorax 2019;74:309-12.
44. Bozyk PD, Moore BB. Prostaglandin E and the Pathogenesis
2
of Pulmonary Fibrosis. Am J Respir Cell Mol Biol doi: 10.1136/thoraxjnl-2018-211897
2011;45:445-52. 55. O’Reilly S. MicroRNAs in Fibrosis: Opportunities and
doi: 10.1165/rcmb.2011-0025RT Challenges. Arthritis Res Ther 2016;18:11.
45. Goodwin A, Jenkins G. Role of Integrin-Mediated TGFbeta doi: 10.1186/s13075-016-0929-x
Activation in the Pathogenesis of Pulmonary Fibrosis. 56. Li H, Zhao X, Shan H, Liang H. MicroRNAs in Idiopathic
Biochem Soc Trans 2009;37:849-54. Pulmonary Fibrosis: Involvement in Pathogenesis and
doi: 10.1042/BST0370849 Potential use in Diagnosis and Therapeutics. Acta Pharm
Sin B 2016;6:531-9.
46. Radisky DC. Epithelial-Mesenchymal Transition. J Cell Sci
2005;118:4325-6. doi: 10.1016/j.apsb.2016.06.010
doi: 10.1242/jcs.02552 57. Chen X, Shi C, Wang C, Liu W, Chu Y, Xiang Z, et al. The Role

Volume 11 Issue 2 (2025) 39 doi: 10.36922/JCTR025080009